Among the examined laboratory parameters, ALT, AST, ALP, and triglyceride levels were elevated in patients with NAFLD, indicating hepatic inflammation and metabolic abnormalities. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.